Evvy, a pioneering women’s health company specialising in precision care focused on the vaginal microbiome, founded in 2021 and headquartered in New York, has introduced its latest breakthrough product: Evvy Women’s Complete Probiotic. This innovative once-daily supplement is designed to provide comprehensive support for the gut, vaginal, and urinary microbiomes , a trio of interconnected systems crucial to women’s overall wellbeing.
Unlike many probiotics on the market that focus solely on one aspect of health, Evvy’s new formulation aims to nurture the entire microbiome ecosystem that influences a woman’s health. The supplement incorporates clinically studied Lactobacillus strains, known to encourage the growth of beneficial bacteria, maintain yeast balance, and alleviate bloating. It also features patented delayed release capsules, which help ensure the probiotics survive the harsh environment of the gastrointestinal tract. Additionally, the product is enriched with postbiotics and vitamins D and E to enhance immune function and support the integrity of the gut barrier.
“At Evvy, our research across over 50,000 women has shown just how deeply interconnected the gut, urinary, and vaginal microbiomes are — yet most products continue to treat them in isolation,” said Pita Navarro, Co-founder and Chief Science Officer at Evvy. “That’s why we created a formulation that finally reflects the science: a single research-backed capsule that supports the full picture of women’s microbiome health.”
This launch further extends Evvy’s pioneering work in vaginal healthcare, which already includes the world’s first at-home Vaginal Microbiome Test utilising cutting-edge metagenomic sequencing, alongside precision prescription treatments. Drawing on insights from the largest real-world vaginal microbiome dataset, Evvy Women’s Complete Probiotic is positioned as a proactive daily essential aimed at supporting women’s gut, urinary, and vaginal health in a holistic manner.
About Evvy
Founded in 2021, Evvy is closing the gender health gap by leveraging overlooked female biomarkers, starting with the vaginal microbiome. The company offers the world’s first Vaginal Microbiome Test powered by metagenomic sequencing, analyzing over 700 microbes with a single, at-home swab — including those related to bacterial vaginosis, yeast infections, fertility outcomes, and more. Evvy’s care platform also includes precision treatment pathways from licensed clinicians and 1:1 health coaching. Through their test and care platform, Evvy has built the world’s largest dataset on the vaginal microbiome, and they are leveraging this novel data to improve outcomes across women’s health.
